Federated Healthcare Model Training for Privacy-Preserving Validation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Healthcare models are typically trained on data from limited geographical regions, leading to generalization weaknesses and high costs and regulatory barriers for FDA approval, requiring extensive data acquisition and validation across diverse populations.
Innovation Solution
A federated learning system that enables model development using pseudonymized or deidentified data from multiple sites, allowing collaboration without sharing actual datasets, and utilizing a server to manage model training and validation across client agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If healthcare models are trained on data from a single hospital or limited geographical regions, then training costs and data acquisition time are reduced, but model generalization capability and robustness deteriorate
Solution Approach 1:
The patent segments the centralized training process into distributed federated learning across multiple hospitals. Each hospital maintains its data locally while contributing to global model training, enabling diverse population exposure without centralizing data. This segmentation allows models to learn from multiple geographical regions while maintaining training efficiency through parallel processing.
Solution Approach 2:
The patent introduces a federated learning platform as an intermediary that coordinates model training across multiple hospitals without requiring direct data sharing. The platform manages model distribution, aggregation, and validation, enabling collaborative training while preserving data privacy and reducing direct coordination overhead between institutions.
2Reliability
If data from multiple sites is acquired for FDA approval validation, then model robustness and regulatory compliance improve, but costs and time requirements increase
Solution Approach 1:
The patent performs preliminary federated validation across multiple sites during the model development phase, before FDA submission. By conducting validation studies across diverse populations in advance through the federated platform, the system prepares regulatory-compliant evidence without requiring additional time-consuming data acquisition and validation processes after model development.
Solution Approach 2:
The patent merges model training and validation processes into a single federated learning workflow. Multiple hospitals simultaneously contribute to both training and validation, eliminating the need for separate validation studies and reducing the overall time required for regulatory compliance while maintaining robust model performance.
3Reliability
If actual datasets are shared across multiple hospitals for model training, then model performance on diverse populations improves, but data privacy and security requirements worsen
Solution Approach 1:
The patent introduces federated learning as an intermediary mechanism that enables model training across multiple hospitals without direct data sharing. The system distributes model parameters and aggregates gradients through a central server, allowing diverse population data to contribute to model performance while maintaining data privacy through mathematical abstraction and local processing.
Solution Approach 2:
The patent creates and distributes copies of the model across multiple hospitals rather than sharing original datasets. Each hospital maintains local data while hosting model copies, enabling training on diverse populations through local model instances that communicate only model parameters, not patient data, thus preserving privacy while improving generalization.
Data Source
AI summary
Systems and methods are provided that utilize a federated learning system for model development.